Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques

Journal of Reproduction and Development

Volumn 60, Issue 3, 2014, Pages 238-245

  Jaroenporn, Sukanya ^a   Urasopon, Nontakorn ^b   Watanabe, Gen ^c,d   Malaivijitnond, Suchinda ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UBON RATCHATHANI UNIVERSITY   (Thailand)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^d GIFU UNIVERSITY   (Japan)

Author keywords

Menopause; Phytoestrogens; Sex skin color; Vaginal dryness

Indexed keywords

PHYTOESTROGEN; PLANT EXTRACT;

ADVERSE EFFECTS; ANIMAL; ATROPHY; CHEMISTRY; CLINICAL TRIAL; DRUG EFFECTS; FEMALE; MACACA FASCICULARIS; MEDICINAL PLANT; MONKEY DISEASES; PATHOLOGY; PHYTOTHERAPY; POSTMENOPAUSE; PROCEDURES; PUERARIA; TOPICAL DRUG ADMINISTRATION; VAGINA; VAGINAL DISEASES; VETERINARY;

ADMINISTRATION, TOPICAL; ANIMALS; ATROPHY; FEMALE; MACACA FASCICULARIS; MONKEY DISEASES; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; POSTMENOPAUSE; PUERARIA; VAGINA; VAGINAL DISEASES;

EID: 84903788654     PISSN: 09168818     EISSN: 13484400     Source Type: Journal    
DOI: 10.1262/jrd.2013-144     Document Type: Article

References (55)

1. Hextall A. Oestrogens and lower urinary tract function. Maturitas 2000; 36: 83-92. [Medline] [CrossRef]
2. Stenberg A, Heimer G, Ulmsten U, Cnattingius S. Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Maturitas 1996; 24: 31-36. [Medline] [CrossRef]
3. Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000; 61: 3090-3096. [Medline]
4. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006; 18: CD001500. [Medline]
5. Lynch C. Vaginal estrogen therapy for the treatment of atrophic vaginitis. J Womens Health (Larchmt) 2009; 18: 1595-1606. [Medline] [CrossRef]
6. Al-Baghdadi O, Ewies AA. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview. Climacteric 2009; 12: 91-105. [Medline] [CrossRef]
7. Geller SE, Studee L. Botanical and dietary supplements for menopausal symptoms: what works, what does not. J Womens Health (Larchmt) 2005; 14: 634-649. [Medline] [CrossRef]
8. Malaivijitnond S. Medical applications of phytoestrogens from the Thai herb Pueraria mirifica. Fr Medecine 2012; 6: 8-21. [Medline] [CrossRef]
9. Cherdshewasart W, Kitsamai Y, Malaivijitnond S. Evaluation of the estrogenic activity of the wild Pueraria mirifica by vaginal cornification assay. J Reprod Dev 2007; 53: 385-393. [Medline] [CrossRef]
10. Malaivijitnond S, Kiatthaipipat P, Cherdshewasart W, Watanabe G, Taya K. Different effects of Pueraria mirifica, a herb containing phytoestrogens, on LH and FSH secretion in gonadectomized female and male rats. J Pharmacol Sci 2004; 96: 428-435. [Medline] [CrossRef]
11. Malaivijitnond S, Chansri K, Kijkuokul P, Urasopon N, Cherdshewasart W. Using vaginal cytology to assess the estrogenic activity of phytoestrogen-rich herb. J Ethnopharmacol 2006; 107: 354-360. [Medline] [CrossRef]
12. Malaivijitnond S, Tungmunnithum D, Gittarasanee S, Kawin K, Limjunyawong N. Puerarin exhibits weak estrogenic activity in female rats. Fitoterapia 2010; 81: 569-576. [Medline] [CrossRef]
13. Manonai J, Chittacharoen A, Theppisai U, Theppisai H. Effect of Pueraria mirifica on vaginal health. Menopause 2007; 14: 919-924. [Medline] [CrossRef]
14. Urasopon N, Hamada Y, Asaoka K, Poungmali U, Malaivijitnond S. Isoflavone content of rodent diets and its estrogenic effect on vaginal cornification in Pueraria mirificatreated rats. Sci Asia 2008; 34: 371-376. [CrossRef]
15. Robinson D, Register TC, Carter LR. The effects of delayed hormone replacement therapy on estrogen receptors of the cynomolgus monkey bladder and vagina. Neurourol Urodyn 1998; 17: 241-247. [Medline] [CrossRef]
16. Schmidt S, Degen GH, Seibel J, Hertrampf T, Vollmer G, Diel P. Hormonal activity of combinations of genistein, bisphenol A and 17β-estradiol in the female Wistar rat. Arch Toxicol 2006; 80: 839-845. [Medline] [CrossRef]
17. Skala CE, Petry IB, Albrich SB, Puhl A, Naumann G, Koelbl H. The effect of hormonal status on the expression of estrogen and progesterone receptor in vaginal wall and periurethral tissue in urogynecological patients. Eur J Obstet Gynecol Reprod Biol 2010; 153: 99-103. [Medline] [CrossRef]
18. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-4263. [Medline]
19. Trisomboon H, Malaivijitnond S, Watanabe G, Taya K. Estrogenic effects of Pueraria mirifica on the menstrual cycle and hormone-related ovarian functions in cyclic female cynomolgus monkeys. J Pharmacol Sci 2004; 94: 51-59. [Medline] [CrossRef]
20. Trisomboon H, Malaivijitnond S, Watanabe G, Cherdshewasart W, Taya K. The estrogenic effect of Pueraria mirifica on gonadotrophin levels in aged monkeys. Endocrine 2006; 29: 129-134. [Medline] [CrossRef]
21. Kavanagh K, Koudy Williams J, Wagner JD. Naturally occurring menopause in cynomolgus monkeys: changes in hormone, lipid, and carbohydrate measures with hormonal status. J Med Primatol 2005; 34: 171-177. [Medline] [CrossRef]
22. Wood CE, Appt SE, Clarkson TB, Franke AA, Lees CJ, Doerge DR, Cline JM. Effects of high-dose soy isoflavones and equol on reproductive tissues in female cynomolgus monkeys. Biol Reprod 2006; 75: 477-486. [Medline] [CrossRef]
23. Dixson AF. Primate Sexuality: Comparative Studies of the Prosimians, Monkeys, Apes and Human Beings. New York: Oxford University Press; 1998.
24. Engelhardt A, Hodges JK, Niemitz C, Heistermann M. Female sexual behavior, but not sex skin swelling, reliably indicates the timing of the fertile phase in wild long-tailed macaques (Macaca fascicularis). Horm Behav 2005; 47: 195-204. [Medline] [CrossRef]
25. Trisomboon H, Malaivijitnond S, Cherdshewasart W, Watanabe G, Taya K. Effect of Pueraria mirifica on the sexual skin coloration of aged menopausal cynomolgus monkeys. J Reprod Dev 2006; 52: 537-542. [Medline] [CrossRef]
26. Malaivijitnond S, Hamada Y, Suryobroto B, Takenaka O. Female long-tailed macaques with scrotum-like structure. Am J Primatol 2007; 69: 721-735. [Medline] [CrossRef]
27. Samsioe G. Urogenital aging-a hidden problem. Am J Obstet Gynecol 1998; 178: S245-S249. [Medline] [CrossRef]
28. Roth GS, Mattison JA, Ottinger MA, Chachich ME, Lane MA, Ingram DK. Aging in rhesus monkeys: relevance to human health interventions. Science 2004; 305: 1423-1426. [Medline] [CrossRef]
29. Mohanty D, Das KC. Effect of folate deficiency on the reproductive organs of female rhesus monkeys: a cytomorphological and cytokinetic study. J Nutr 1982; 112: 1565-1576. [Medline]
30. Lillie RD. Histologie Technic and Practical Histochemistry, 3rd ed. New York: McGraw-Hill Book; 1965: 561-564.
31. Hamada Y, Suryobroto B, Goto S, Malaivijitnond S. Morphological and body color variation in Thai Macaca fascicularis fascicularis north and south of the Isthmus of Kra. Int J Primatol 2008; 29: 1271-1294. [CrossRef]
32. Kaari C, Haidar MA, Júnior JM, Nunes MG, Quadros LG, Kemp C, Stavale JN, Baracat EC. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 2006; 53: 49-58. [Medline] [CrossRef]
33. Cline JM, Botts S, Lees CJ, Brommage R. Effects of lasofoxifene on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macacafascicularis). Am J Obstet Gynecol 2008; 199: 158. e1-158. e8.
34. Mehta RR, Jenco JM, Gaynor LV, Chatterton RT Jr. Relationships between ovarian morphology, vaginal cytology, serum progesterone, and urinary immunoreactive pregnanediol during the menstrual cycle of the cynomolgus monkey. Biol Reprod 1986; 35: 981-986. [Medline] [CrossRef]
35. Chen GD, Oliver RH, Leung BS, Lin LY, Yeh J. Estrogen receptor alpha and beta expression in the vaginal walls and uterosacral ligaments of premenopausal and postmenopausal women. Fertil Steril 1999; 71: 1099-1102. [Medline] [CrossRef]
36. Flickinger GL, Elsner C, Illingworth DV, Muechler EK, Mikhail G. Estrogen and progesterone receptors in the female genital tract of humans and monkeys. Ann N Y Acad Sci 1977; 286: 180-189. [Medline] [CrossRef]
37. Jensen EV, Suzuki T, Numata M, Smith S, DeSombre ER. Estrogen-binding substances of target tissues. Steroids 1969; 13: 417-427. [Medline] [CrossRef]
38. Rimoldi G, Christoffel J, Seidlova-Wuttke D, Jarry H, Wuttke W. Effects of chronic genistein treatment in mammary gland, uterus, and vagina. Environ Health Perspect 2007; 115(Suppl 1): 62-68. [Medline] [CrossRef]
39. Le Donne M, Caruso C, Mancuso A, Costa G, Iemmo R, Pizzimenti G, Cavallari V. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause. Arch Gynecol Obstet 2011; 283: 1319-1323. [Medline] [CrossRef]
40. Bachmann G, Bouchard C, Hoppe D, Ranganath R, Altomare C, Vieweg A, Graepel J, Helzner E. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally. Menopause 2009; 16: 719-727. [Medline] [CrossRef]
41. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun 1999; 67: 5170-5175. [Medline]
42. MacBride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010; 85: 87-94. [Medline] [CrossRef]
43. Pabich WL, Fihn SD, Stamm WE, Scholes D, Boyko EJ, Gupta K. Prevalence and determinants of vaginal flora alterations in postmenopausal women. J Infect Dis 2003; 188: 1054-1058. [Medline] [CrossRef]
44. Heinemann C, Reid G. Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy. Can J Microbiol 2005; 51: 777-781. [Medline] [CrossRef]
45. Johnson MH, Everitt BJ. Essential Reproduction, 6th ed. Massachusetts: Blackwell Publishing; 2007: 102-132.
46. Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, Martel C, Labrie C. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Menopause 2009; 16: 30-36. [Medline] [CrossRef]
47. Nilsson K, Heimer G. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency-a pharmacokinetic and pharmacodynamic study. Maturitas 1992; 15: 121-127. [Medline] [CrossRef]
48. Schmidt G, Andersson SB, Nordle O, Johansson CJ, Gunnarsson PO. Release of 17-beta-oestradiol from a vaginal ring in postmenopausal women: pharmacokinetic evaluation. Gynecol Obstet Invest 1994; 38: 253-260. [Medline] [CrossRef]
49. Czaja JA, Robinson JA, Eisele SG, Scheffler G, Goy RW. Relationship between sexual skin colour of female rhesus monkeys and midcycle plasma levels of oestradiol and progesterone. J Reprod Fertil 1977; 49: 147-150. [Medline] [CrossRef]
50. Wallner B, Aspernig D, Millesi E, Machatschke IH. Non-lactating versus lactating females: a comparison of sex steroids, sexual coloration, and sexual behavior in Japanese macaques. Primates 2011; 52: 69-75. [Medline] [CrossRef]
51. Wallen K, Goy RW. Effects of estradiol benzoate, estrone, and propionates of testosterone or dihydrotestosterone on sexual and related behaviors of ovariectomized Rhesus monkeys. Horm Behav 1977; 9: 228-248. [Medline] [CrossRef]
52. Baulu J. Seasonal sex skin coloration and hormonal fluctuations in free-ranging and captive monkeys. Horm Behav 1976; 7: 481-494. [Medline] [CrossRef]
53. Muangman V, Cherdshewasart W. Clinical trial of the phytoestrogen rich herb, Pueraria mirifica as a crude drug in the treatment of symptoms in menopausal woman. Siriraj Hosp Gaz 2001; 53: 300-309.
54. Urasopon N, Hamada Y, Cherdshewasart W, Malaivijitnond S. Preventive effects of Pueraria mirifica on bone loss in ovariectomized rats. Maturitas 2008; 59: 137-148. [Medline] [CrossRef]
55. Wattanapitayakul SK, Chularojmontri L, Srichirat S. Effects of Pueraria mirifica on vascular function of ovariectomized rabbits. J Med Assoc Thai 2005; 88(Suppl 1): S21-S29. [Medline]